Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Red blood cells (erythrocytes) are specialized, anucleate cells responsible for transporting oxygen from the lungs to body tissues and facilitating carbon dioxide removal back to the lungs. Their primary functional component is hemoglobin, a metalloprotein that binds oxygen reversibly at high concentrations in the lung and releases it in peripheral tissues where it is needed for cellular respiration. The biconcave shape and flexible membrane allow them to traverse narrow capillaries efficiently. In addition to their classical role in gas exchange, red blood cells also participate in regulating vascular tone by releasing vasodilatory molecules such as nitric oxide and ATP under hypoxic conditions, thereby matching local tissue perfusion with metabolic demand. Increasing the number of circulating erythrocytes—through endogenous mechanisms like elevated erythropoietin secretion during hypoxia or exogenous interventions—raises total oxygen-carrying capacity but carries risks if not properly regulated.[1][2][3][4][5][6]
For drugs increasing circulating erythrocytes: - Stimulate bone marrow production of red blood cells by mimicking or enhancing endogenous erythropoietin activity[3]. - Supplement iron for hemoglobin synthesis. - Direct transfusion increases circulating RBC mass.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Red blood cell (erythrocyte) (RBC).